Dr. Peter Bonis, chief medical officer at Wolters Kluwer Health, says the acquisition of drug-diversion company Invistics is helping to route appropriate medications to the right patients.  

Northwell Health and Nuvance Health, both nonprofits, have entered into a strategic agreement to form a new integrated regional health system serving communities across two states. The proposed agreement will allow the organizations to come together formally once regulatory approvals are squared away.

The Food and Drug Administration has announced its final decision to withdraw approval of Pepaxto, which was approved for use in combination with dexamethasone to treat certain patients with multiple myeloma.

MGMA, the Medical Group Management Association, said it is getting alarming feedback about how physician practices have been impacted by the Change Healthcare cybersecurity attack. Change confirmed today that ALPHV/Blackcat perpetrated the cybercrime.